Vasoactive intestinal peptide and pituitary adenylate cyclase- activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages

Journal of Leukocyte Biology

Volumn 63, Issue 5, 1998, Pages 591-601

  Martínez, Carmen ^a   Delgado, Mario ^a   Pozo, David ^b   Leceta, Javier ^a   Calvo, Juan R ^b   Ganea, Doina ^c   Gomariz, Rosa P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Cytokines; Lipopolysaccharide; Neuropeptides

Indexed keywords

ENDOTOXIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; INTERLEUKIN 6; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALIA; MURINAE;

EID: 2642701709     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.63.5.591     Document Type: Article

References (42)

1. De La Fuente, M., Delgado, M., Gomariz, R. P. (1996) VIP modulation of immune cell functions. Adv. Neuroimmunol. 6, 75-91.
2. + thymocytes from glucocorticoid-induced apoptosis. Blood 87, 5152-5161.
3. Gomariz, R. P., Leceta, J., Garrido, E., Garrido, T., Delgado, M. (1993) Vasoaetive intestinal peptide (VIP) mRNA expression m rat T and B lymphocytes. Reg. Pept. 50, 177-184.
4. Leceta, J., Martinez, C., Delgado, M., Garrido, E., Gomariz, R. P. (1996) Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system. Adv. Neuroimmunol. 6, 29-36.
5. Gaytan, F., Martinez-Fuentes, A. J., Gracia-Navarro, F., Vaudry, H., Aguilar, E. (1994) Pituitary adenylate cyclase-activating polypeptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell Tissue Res. 276, 223-227.
6. Rawlings, S. R. (1994) PACAP, PACAP receptors, and intracellular signalling. Mol. Cell. Endocrinol. 101, C5-C9.
7. Calvo, J. R., Pozo, D., Guerrero, J. M. (1996) Functional and molecular characterization of VIP receptors and signal transduction in human and rodent immune systems. Adv. Neuroimmunol. 6, 39-47.
8. Weinstock, J. V. (1996) Vasoactive intestinal peptide regulation of granulomatous inflammation in murine Schistosomiasis mansoni. Adv. Neuroimmunol. 6, 95-105.
9. Wang, H. Y., Xin, Z., Tang, H., Ganea, D. (1996) Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism. J. Immunol. 156, 3243-3253.
10. Ganea, D. (1996) Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol. 6, 61-74.
11. Xin, Z., Tang, H., Ganea, D. (1994) Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via TCR/CD3 complex. J. Neuroimmunol. 54, 59-68.
12. Martinez, C., Delgado, M., Gomariz, R. P., Ganea, D. (1996) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes. J. Immunol. 156, 4128-4136.
13. Van Snick, J. (1990) Interleukin-6: an overview. Annu. Rev. Immunol. 8, 253-278.
14. Morrison, D. C., Ryan, J. L. (1979) Bacterial endotoxins and host immune responses. Adv. Immunol. 28, 293-299.
15. Bost, K. L., Mason, M. J. (1995) Thapsigargin and cyclopiazonic acid initiate rapid and dramatic increases of IL-6 mRNA expression and IL-6 secretion in murine peritoneal macrophages. J. Immunol. 155, 285-296.
16. Grenett, H. E., Fuentes, N. L., Fuller, G. M. (1990) Cloning and sequence analysis of the cDNA for murine interleukin-6. Nucleic Acids Res. 18, 6455-6461.
17. Gomariz, R. P., Garrido, E., Leceta, J., Martinez, C., Abalo, R.. Delgado, M. (1994) Gene expression of VIP receptor in rat lymphocytes. Biochem. Biophys. Res. Commun. 203, 1599-1604.
18. Tatsuno. I., Gottschall, P. E., Arimura, A. (1991) Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase-activating polypeptide: a comparative study with vasoactive intestinal peptide. Endocrinol. 128, 728-734.
19. Pozo, D., Delgado, M., Martinez, C., Gomariz, R. P., Guerrero, G. M., Calvo, J. R. Functional characterization and mRNA expression of pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages. Biochim. Biophys. Acta (in press).
20. Ottaway, C. A., Greenberg, G. R. (1984) Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and modulation of mitogen response. J. Immunol. 132, 417-423.
21. Gourlet, P., Vandermeers, A., Vandermeers-Piret, M. C., Rathe, J., De Neef, P., Robberecht, P. (1995) Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. Eur. J. Pharmacol. 287, 7-11.
22. 2 as a VIP antagonist. Endocrinol. 116, 2643-2649.
23. Uchida, D., Arimura, A., Somogyvári-Vigh, A., Shioda, S., Banks, W. A. (1996) Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res. 736, 280-286.
24. Said, S. I. (1985) Vasoactive intestinal peptide. In Airways Smooth Muscle: Peptide Receptors, Ion Channels and Signal Transduction (D. Raeburn and M. A. Giembycz, eds.) Basel: Switzerland: Birkhauser Verlag, 87-113.
25. Foda, H. D., Iwanaga, T., Liu, L. W., Said, S. I. (1988) Vasoactive intestinal peptide protects against HCl-induced pulmonary edema in rats. Ann. NY Acad. Sci. 527, 633-639.
26. Berisha, H., Foda, H. D., Sakakibara, H., Trotz, D., Pakbaz, H., Said, S. Y. (1990) Vasoactive intestinal peptide prevents lung injury due to xanthine/ xanthine oxidase. Am. J. Physiol. 259, L151-L158.
27. Kurosawa, M., Ishizuka, T. (1993) Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by N-formyl-methionyl-leucyl-phenylalanine-activated inflammatory cells in vitro. Int. Arch. Allergy Appl. Immunol. 100, 28-35.
28. Pozo, D., Guerrero, J. M., Calvo, J. R. (1995) Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages. Peptides 16, 313-318.
29. Delgado, M., Pozo, D., Martinez, C., Garrido, E., Leceta, J., Calvo, J. R., Gomariz, R. P. (1996) Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages. Reg. Peptides 62, 161-166.
30. Calvo, J. R., Montilla, M. L., Guerrero, J. M., Segura, J. J. (1994) Expression of VIP receptors in mouse peritoneal macrophages: Functional and molecular characterization. J. Neuroimmunol. 50, 85-93.
31. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., Hidaka, H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromociannamylamino)ethyl]-5-isoquinoleinsulfonamide (H89), of PC12D pheochro-mocytoma cells. J. Biol. Chem. 265, 5267-5272.
32. Kobayashi, E., Nakno, H., Morimoto M., Tamaoki, T. (1989) Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159, 548-553.
33. De La Fuente, M., Delgado, M., Del Rio, M., Garrido, E., Leceta, J., Hernanz, A., Gomariz, R. P. (1994) Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages. Peptides 15, 1157-1163.
34. De La Fuente, M., Delgado, M., Del Rio, M., Martinez, C., Hernanz, A., Gomariz, R. P. (1993) Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function of rat macrophages. Protein kinase C involvement. Reg. Peptides 48, 345-353.
35. Delgado, M., Garrido, E., De La Fuente, M., Gomariz, R. P. (1996) Pituitary adenylate cyclase-activating polypeptide (PACAP38) stimulates rat peritoneal macrophages functions. Peptides 17, 1097-1105.
36. Garrido, E., Delgado, M., Martinez, C., Gomariz, R. P., De La Fuente, M. (1996) Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility. Neuropeptides 30, 583-595.
37. Cauvin, A., Buscail, L., Gourlet, P., De Neef, P., Gossen, D., Arimura, A., Miyata, A., Coy, D. H., Robberecht, P., Christophe, J. (1990) The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides 11, 773-777.
38. Kovacx, C. S., Chik, C. L., Li, B., Karpinski, E., Ho, A. K. (1996) Pituitary adenylate cyclase-activating peptide stimulates cyclic AMP accumulation in UMR 106 osteoblast-like cells. J. Endocrinol. 149, 287-295.
39. Bouma, M. G., Stad, R. K., Van Den Wildenberg, F. A. J. M., Buurman, W. A. (1994) Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153, 4159-4168.
40. Baumann, H., Symes, A. J., Comeau, M. R., Morella, K. K., Wang, Y., Friend, D., Ziegler, S. F., Fink, J. S., Gearing, D. P. (1994) Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol. Cell. Biol. 14, 138-146.
41. Kaltreider, H. B., Ichikawa, S., Byrd, P. K., Ingram, D. A., Kishiyama, J. L., Sreedharan, S. P., Warnock, M. L., Beck, J. M., Goetzl, E. J. (1997) Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am. J. Respir. Cell. Mol. Biol. 16, 133-144.
42. Segura, J. J., Guerrero, J. M., Pozo, D., Calvo, J. R. (1996) Expression of vasoactive intestinal peptide binding sites in rat peritoneal macrophages is stimulated by inflammatory stimulus. J. Neuroimmunol. 64, 1-7.